ArticleDiabetes & metabolic syndrome
Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
Article in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review.Health informatics journalPooled it
- Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review.Journal of clinical & translational endocrinology · 2024Article
- Article
- 3D scanning of a carburetor body using COMET 3D scanner supported by COLIN 3D software: Issues and solutions.Materials today. Proceedings · 2021Article
- Diagnosis of a Case of Suspected COVID-19 Using Telemedicine Technology in the Emergency Department.The American journal of case reports · 2020Article
- Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them.Diabetes & metabolic syndromeReview
- Letter to the editor in response to: COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India (Gopalan and Misra).Diabetes & metabolic syndromeArticle
- Redefining diabetic foot disease management service during COVID-19 pandemic.Diabetes & metabolic syndromeReview
- Users' perspectives about challenges of using telemedicine for patient with diabetes during the COVID-19 pandemic.Digital healthArticle
Corrections and comments
- Comment on
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.